Functional interactions of the ALK+ ALCL cells with bone marrow stroma cells lead to fibroblast activation (CAFs) and alter the cytokine profile of the TME, which may contribute to tumor aggressiveness and possibly resistance to treatment. This evidence concerns the gene ALK and neoplasm.